Thermo Fisher Scientific (TMO) Other financing activities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other financing activities for 18 consecutive years, with $39.0 million the latest figure, recorded in Q1 2026.

• Other financing activities for Q1 2026 came in at $39.0 million, down 13.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.0 million (down 35.38% YoY), and the FY2025 annual result was $90.0 million, down 53.85% from the prior year.
• Other financing activities was $39.0 million for Q1 2026 at Thermo Fisher Scientific, down from $91.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $110.0 million in Q1 2024 and troughed at -$42.0 million in Q2 2025.
• Average Other financing activities over 5 years is $21.8 million, with a median of $20.0 million recorded in 2022.
• Year-over-year, Other financing activities slumped 270.0% in 2022 and soared 775.0% in 2024.
• Over 5 years, Other financing activities stood at $20.0 million in 2022, then slipped by 30.0% to $14.0 million in 2023, then slumped by 221.43% to -$17.0 million in 2024, then surged by 635.29% to $91.0 million in 2025, then plunged by 57.14% to $39.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $39.0 million in Q1 2026, $91.0 million in Q4 2025, and -$4.0 million in Q3 2025.